Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 12.8

Adjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2006 - 2007) (Tx 2006 - 2007) (Tx 2002 - 2007) (Tx 1997 - 2007)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,855 91.8% 0.5% 2,855 82.2% 0.7% 7,503 50.6% 0.8% 12,085 24.8% 0.8%
Lung Diagnosis Group Group A: Obstructive Lung Disease 1,092 91.9% 2.8% 1,092 81.1% 5.9% 3,311 40.0% 5.1% 5,848 16.3% 2.8%
Group B: Pulmonary Vascular Disease 102 91.7% 7.0% 102 86.2% 11.1% 307 50.8% 14.2% 554 30.3% 8.8%
Group C: Cystic Fibrosis or Immunodef. Disorders 438 88.5% 10.8% 438 72.6% 22.9% 1,152 53.4% 11.2% 1,883 32.9% 7.3%
Group D: Restrictive Lung Disease 1,164 93.4% 1.9% 1,164 85.9% 3.7% 2,566 59.0% 3.9% 3,476 32.1% 3.5%
Group E: Age Less Than 12 39 72.3% 17.7% 39 60.5% 21.3% 105 60.7% 8.1% 204 37.7% 7.1%
Other Diagnosis 20 94.5% 5.5% 20 94.5% 5.5% 62 63.5% 8.2% 120 28.5% 8.0%


Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.



PDF FormatRequires Adobe Acrobat Reader